|
Crohn's Disease
|
|
Crohn's disease; Crohn//'s disease; Inflamatory Bowel Disease; Inflammatory Bowel Disease, Crohn's
|
Crohn's Disease Clinical Trials
- Trial of Growth Hormone Therapy in Pediatric Crohn's Disease
ClinicalTrials.gov Identifier: NCT00109473 - Active, not recruiting
Crohn's Disease
- Remission in Subjects with Crohn's Disease
ClinicalTrials.gov Identifier: NCT00055497 - Active, not recruiting
Crohn's Disease
- Alicaforsen (ISIS 2302) in Patients with Active Crohn's Disease
ClinicalTrials.gov Identifier: NCT00048295 - Active, not recruiting
Crohn's Disease
- Safety and Efficacy of ALX-0600 in Subjects with Active Crohn's Disease
ClinicalTrials.gov Identifier: NCT00072839 - Active, not recruiting
Crohn's Disease
- SONIC: Study of Biologic and Immunomodulator Naïve Patients in Crohn's Disease
ClinicalTrials.gov Identifier: NCT00094458 - Active, not recruiting
Crohn's Disease
- Controlled Trial of 4-Aminosalicylic Acid in Patients with Small Bowel Crohn's Disease
ClinicalTrials.gov Identifier: NCT00004423 - Active, not recruiting
Crohn's Disease
- Prochymal™ Adult Human Mesenchymal Stem Cells for Treatment of Moderate-to-Severe Crohn's Disease
ClinicalTrials.gov Identifier: NCT00294112 - Active, not recruiting
Crohn's Disease
- Imuran (azathioprine) Dose-Ranging Study in Crohn's Disease
ClinicalTrials.gov Identifier: NCT00098111 - Recruiting
Crohn's Disease
- Effects of Adalimumab on Mucosal Healing in Subjects With Crohn's Disease Involving the Colon
ClinicalTrials.gov Identifier: NCT00348283 - Active, not recruiting
Crohn's Disease
- Safety and Efficacy of Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Crohn's Disease
ClinicalTrials.gov Identifier: NCT00221026 - Active, not recruiting
Crohn's Disease
- A Study of Adalimumab for the Induction of Clinical Remission in Japanese Subjects With Crohn's Disease
ClinicalTrials.gov Identifier: NCT00445939 - Active, not recruiting
Crohn's Disease
- Study Evaluating ERB-041 in Active Crohn's Disease
ClinicalTrials.gov Identifier: NCT00245947 - Active, not recruiting
Crohn's Disease
- Can CT Enteroclysis Predict the Outcome of Crohn's Disease
ClinicalTrials.gov Identifier: NCT00572780 - Active, not recruiting
Crohn's Disease
- A Randomized Controlled Trial of VSL#3 for the Prevention of Endoscopic Recurrence Following Surgery for Crohn's Disease.
ClinicalTrials.gov Identifier: NCT00175292 - Recruiting
Crohn's Disease; Inflammatory Bowel Disease
- TREAT: The Crohn's Therapy, Resource, Evaluation, and Assessment Tool Registry
ClinicalTrials.gov Identifier: NCT00553176 - Active, not recruiting
Crohn's Disease
- Certolizumab Pegol for Treatment of Adult Greek Population With Moderate to Severe Crohn's Disease, Who Failed on Infliximab
ClinicalTrials.gov Identifier: NCT00307931 - Recruiting
Crohn's Disease
- Extension Study to Evaluate Safety, Efficacy, and Corticosteroid Sparing Effect of Certolizumab in Patients With Crohn's Disease.
ClinicalTrials.gov Identifier: NCT00356408 - Recruiting
Crohn's Disease
- A 5-Year Registry Study of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
ClinicalTrials.gov Identifier: NCT00524537 - Recruiting
Crohn's Disease
- Placebo Controlled Study of 3 Doses of Rifaximin-EIR Tablet to Treat Moderate, Active Crohn's Disease
ClinicalTrials.gov Identifier: NCT00528073 - Recruiting
Crohn's Disease
- The Effect on Mucosal Healing With Pentasa Sachet in Mild to Moderate Active Crohn's Disease
ClinicalTrials.gov Identifier: NCT00245505 - Recruiting
Crohn's Disease
- A Study to Evaluate the Efficacy and Safety of CCX282-B in Subjects With Moderate to Severe Crohn's Disease
ClinicalTrials.gov Identifier: NCT00306215 - Recruiting
Crohn's Disease
- Endoscopic Severity Score of Small Bowel Crohn's Disease With Wireless Capsule Endoscopy
ClinicalTrials.gov Identifier: NCT00492791 - Recruiting
Crohn's Disease
- Evaluation of Topical 10% Metronidazole Ointment for the Treatment of Active Perianal Crohn's Disease
ClinicalTrials.gov Identifier: NCT00509639 - Recruiting
Crohn's Disease
- An Open-Label Study of Adalimumab for the Induction and Maintenance of Clinical Remission in Subjects With Moderate to Severe Crohn's Disease
ClinicalTrials.gov Identifier: NCT00409617 - Recruiting
Crohn's Disease
- Evaluation of PROCHYMAL[tm] Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease
ClinicalTrials.gov Identifier: NCT00482092 - Recruiting
Crohn's Disease
- Efficacy Study of Targeted, Local Delivery of Drugs to Treat Crohn's Disease
ClinicalTrials.gov Identifier: NCT00287170 - Recruiting
Crohn's Disease
- Clinical Study of CDP870/Certolizumab Pegol in Patients With Active Crohn's Disease
ClinicalTrials.gov Identifier: NCT00291668 - Recruiting
Crohn's Disease
- Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Crohn's Disease
ClinicalTrials.gov Identifier: NCT00409682 - Recruiting
Crohn's Disease
- A Study of Adalimumab for the Maintenance of Clinical Remission in Japanese Subjects With Crohn's Disease
ClinicalTrials.gov Identifier: NCT00445432 - Recruiting
Crohn's Disease
- Treatment of Crohn's Disease With an Antibiotic Regimen Directed Against Mycobacterium Avium Paratuberculosis
ClinicalTrials.gov Identifier: NCT00513552 - Recruiting
Crohn's Disease
- High Dose Oral 4-Aminosalicylic Acid (PASER®) to Control Acute Flares of Mild to Moderate Crohn's Disease in Children
ClinicalTrials.gov Identifier: NCT00495521 - Recruiting
Crohn's Disease
- Extended Evaluation of PROCHYMAL[tm] Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease
ClinicalTrials.gov Identifier: NCT00543374 - Recruiting
Crohn's Disease
- Beta Carotene From Natural Source for Patients With Non-Active Crohn's Disease
ClinicalTrials.gov Identifier: NCT00275418 - Recruiting
Crohn's Disease
- Hematopoietic Stem Cell Support in Patients With Severe Crohn's Disease
ClinicalTrials.gov Identifier: NCT00278577 - Recruiting
Crohn's Disease
- Quality of Life in Pediatric Inflammatory Bowel Disease
ClinicalTrials.gov Identifier: NCT00061737 - Active, not recruiting
Crohn's Disease; Ulcerative Colitis
- Dietary Treatment of Crohn's Disease
ClinicalTrials.gov Identifier: NCT00343642 - Recruiting
Crohn's Disease; Inflammatory Bowel Disease
- A Study of Abatacept in Patients With Active Crohn's Disease
ClinicalTrials.gov Identifier: NCT00406653 - Recruiting
Crohn's Disease
- Efficacy and Safety Study of D9421-C 9 mg and 15 mg Versus Placebo in Japanese Patients With Active Crohn's Disease
ClinicalTrials.gov Identifier: NCT00573469 - Recruiting
Crohn's Disease
- Comparison of a Nutritional Anti-Inflammatory Treatment to Steroids for Pediatric Crohn's Disease - the Molecular Basis
ClinicalTrials.gov Identifier: NCT00265772 - Recruiting
Crohn's Disease; Pediatric
- G-CSF to Treat Crohn's Disease
ClinicalTrials.gov Identifier: NCT00025805 - Recruiting
Crohn's Disease
- Safety of Celecoxib in Patients With Crohn's Disease
ClinicalTrials.gov Identifier: NCT00177866 - Recruiting
Crohn's Disease
- Crohn's Disease Stem Cell Transplantation
ClinicalTrials.gov Identifier: NCT00271947 - Recruiting
Crohn's Disease
- Synbiotic Treatment in Crohn's Disease Patients
ClinicalTrials.gov Identifier: NCT00305409 - Recruiting
Crohn's Disease
- Maintenance Study of CDP870 in Crohn's Disease
ClinicalTrials.gov Identifier: NCT00329550 - Recruiting
Crohn's Disease
- An Efficacy and Safety Evaluation of Inflabloc Cap in the Treatment of Patients with Crohn's Disease
ClinicalTrials.gov Identifier: NCT00106314 - Completed
Crohn's Disease
- Development of Workshop for Lifestyle Changing for Crohn's Disease Patients and Its Affect on the Disease's Indexes
ClinicalTrials.gov Identifier: NCT00376649 - Not yet recruiting
Crohn's Disease
- A Trial Evaluating Safety of Chronic Therapy With Certolizumab Pegol in Crohn's Disease
ClinicalTrials.gov Identifier: NCT00358683 - Not yet recruiting
Crohn's Disease
- Multicenter Trial For Patients With Acute Crohn's Disease
ClinicalTrials.gov Identifier: NCT00035503 - Completed
Crohn's Disease
- Treatment of Perianal Crohn's Disease, Combining Medical and Surgical Treatment.
ClinicalTrials.gov Identifier: NCT00252369 - Recruiting
Crohn's Disease
- Clarithromycin in Active Crohn's Disease
ClinicalTrials.gov Identifier: NCT00269386 - Recruiting
Crohn's Disease
- Early Immunosuppressants in Crohn's Disease
ClinicalTrials.gov Identifier: NCT00546546 - Recruiting
Crohn's Disease
- Dose Ranging Study Comparing the Efficacy, Safety and Pharmacokinetics of Intravenous Infusions of ABT-874 vs Placebo in Subjects With Moderately to Severely Active Crohn's Disease
ClinicalTrials.gov Identifier: NCT00562887 - Not yet recruiting
Crohn's Disease
- Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of Clinical Remission in Subjects with Crohn's Disease
ClinicalTrials.gov Identifier: NCT00105300 - Completed
Crohn's Disease
- A Clinical Trial of Natalizumab in Individuals With Moderately to Severely Active Crohn's Disease
ClinicalTrials.gov Identifier: NCT00078611 - Completed
Crohn's Disease
- Monoclonal Antibody Treatment of Crohn's Disease
ClinicalTrials.gov Identifier: NCT00007163 - Completed
Crohn's Disease
- Immune Regulation in Ulcerative Colitis or Crohn's Disease
ClinicalTrials.gov Identifier: NCT00001184 - Recruiting
Crohn's Disease; Inflammatory Bowel Disease; Ulcerative Colitis
- VSL#3 Treatment in Children With Crohn's Disease
ClinicalTrials.gov Identifier: NCT00367705 - Not yet recruiting
Crohn's Disease
- Adalimumab for the Induction and Maintenance of Clinical Remission in Subjects with Crohn's Disease
ClinicalTrials.gov Identifier: NCT00077779 - Completed
Crohn's Disease
- Safety and Efficacy of Natalizumab in Combination with Remicade in the Treatment of Crohn's Disease
ClinicalTrials.gov Identifier: NCT00055536 - Completed
Crohn's Disease
- Safety, Tolerability and Effectiveness of Natalizumab in Adolescents with Active Crohn's Disease
ClinicalTrials.gov Identifier: NCT00055367 - Completed
Crohn's Disease
- Alicaforsen (ISIS 2302) in Patients with Active Crohn's Disease
ClinicalTrials.gov Identifier: NCT00048113 - Completed
Crohn's Disease
- Certolizumab in Crohn's Disease Patient With Loss of Response or Intolerance to Infliximab
ClinicalTrials.gov Identifier: NCT00308581 - Active, not recruiting
Crohn Disease
- A Study of the Safety and Efficacy of Inflixiamb (Remicade) in Pediatric Patients With Crohn's Disease
ClinicalTrials.gov Identifier: NCT00207675 - Active, not recruiting
Crohn Disease
- Safety and Efficacy of Natalizumab in the Treatment of Crohn's Disease
ClinicalTrials.gov Identifier: NCT00032786 - Completed
Crohn's Disease
- Safety and Efficacy of Natalizumab in the Treatment of Crohn's Disease
ClinicalTrials.gov Identifier: NCT00032799 - Completed
Crohn's Disease
- Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Who Completed Protocol CL0600-008
ClinicalTrials.gov Identifier: NCT00308438 - Active, not recruiting
Crohn Disease
- Study of Immune Ablation With High-Dose Cyclophosphamide and Anti-Thymocyte Globulin Followed By Autologous Peripheral Blood Stem Cell Rescue in Patients With Severe Crohn's Disease
ClinicalTrials.gov Identifier: NCT00014703 - No longer recruiting
Crohn's Disease
- A Phase II Study of the Human Anti-TNF Antibody Adalimumab for the Induction of Clinical Remission in Subjects with Crohn's Disease
ClinicalTrials.gov Identifier: NCT00055523 - Completed
Crohn's Disease
- Infliximab to Treat Crohn's-Like Inflammatory Bowel Disease in Chronic Granulomatous Disease
ClinicalTrials.gov Identifier: NCT00325078 - Recruiting
Chronic Granulomatous Disease; Crohn's-Like IBD; Inflammatory Bowel Disease (IBD)
- Probiotics in GrastroIntestinal Disorders
ClinicalTrials.gov Identifier: NCT00510978 - Active, not recruiting
Ulcerative Colitis; Crohn's Disease
- Glucocorticoid-Induced Osteopenia in Children
ClinicalTrials.gov Identifier: NCT00289328 - Active, not recruiting
Crohn's Disease; Nephrotic Syndrome
- A Study to Evaluate CC-5013 in the Treatment of Adolescents and Adults With Moderately Severe Crohn's Disease
ClinicalTrials.gov Identifier: NCT00446433 - Completed
Crohn's Disease
- The Immunological and Blood Effects of STA-5326 Mesylate on Patients With Crohn's Disease
ClinicalTrials.gov Identifier: NCT00250198 - Completed
Crohn's Disease
- Open Label Natalizumab Safety Extension Study for Subjects With Crohn's Disease
ClinicalTrials.gov Identifier: NCT00280956 - Completed
Crohn's Disease
- Study to Assess the Safety of CDP870 for up to 30 Months Following Reintroduction of Treatment
ClinicalTrials.gov Identifier: NCT00160706 - Active, not recruiting
Crohn's Disease
- Phase III Randomized Study of Anti-Tumor Necrosis Factor Chimeric Monoclonal Antibody (cA2) for Patients with Enterocutaneous Fistulae as a Complication of Crohn's Disease
ClinicalTrials.gov Identifier: NCT00004941 - Completed
Crohn's Disease
- Immune Ablation and Stem Cell Support for Crohn's Disease
ClinicalTrials.gov Identifier: NCT00179842 - Recruiting
Crohn Disease
- Treatment of the Human Anti-TNF Monoclonal Antibody Adalimumab in Moderate to Severe Crohn's Disease With Previous Exposure to Infliximab (CHOICE)
ClinicalTrials.gov Identifier: NCT00338650 - Completed
Crohn's Disease
- Visilizumab for Moderate to Severe Inflammatory, Nonstricturing, Nonpenetrating Crohn's Disease
ClinicalTrials.gov Identifier: NCT00267722 - Completed
Crohn's Disease
- Phase II Study of RR110 in Patients With Active Crohn's Disease
ClinicalTrials.gov Identifier: NCT00417391 - Recruiting
Crohn’s Disease
- Urinary PGE-M, A Metabolite of PGE2: A Novel Biomarker of Crohn's Disease Activity
ClinicalTrials.gov Identifier: NCT00496548 - Recruiting
Crohns Disease
- Stop Infliximab in Patients With Crohn's Disease
ClinicalTrials.gov Identifier: NCT00571337 - Recruiting
Crohn Disease
- Phase 1 Study of Safety and Biological Effects of C326, an Inhibitor of IL-6, in Crohn’s Disease
ClinicalTrials.gov Identifier: NCT00353756 - Recruiting
Crohn's Disease
- Bone Health in Pediatric Crohn's Disease: A Low Magnitude Mechanical Stimulus Trial
ClinicalTrials.gov Identifier: NCT00364130 - Recruiting
Crohn Disease
- The Innate Immune System and Inflammatory Bowel Disease
ClinicalTrials.gov Identifier: NCT00516776 - Recruiting
Ulcerative Colitis; Crohn's Disease; Healthy Controls
- Infectious Agents in Pediatric Crohn's
ClinicalTrials.gov Identifier: NCT00237055 - Completed
Crohn's Disease; Inflammatory Bowel Disease
- A Humanized Anti-Interferon-γ Monoclonal Antibody (HuZAF) for Moderate to Severe Crohn's Disease
ClinicalTrials.gov Identifier: NCT00072943 - Completed
Crohn's Disease; Colitis; Intestinal Disease; Gastrointestinal Disease; Digestive System Disease
- High Dose Oral 4-Aminosalicylic Acid (PASER®) to Control Acute Flares of Mild to Moderate Crohn's Disease
ClinicalTrials.gov Identifier: NCT00417690 - Recruiting
Crohn’s Disease
- Safety and Efficacy of AST-120 in Mild to Moderate Crohn's Patients With Fistulas
ClinicalTrials.gov Identifier: NCT00321412 - Active, not recruiting
Inflammatory Bowel Disease; Intestinal Fistula
- Visilizumab for Treatment of Perianal Fistulas in Crohn's Disease
ClinicalTrials.gov Identifier: NCT00267709 - Completed
Crohn's Disease
- Top Down Versus Step Up Strategies in Crohn's Disease
ClinicalTrials.gov Identifier: NCT00554710 - Completed
Crohn's Disease
- Protein and Energy Metabolism in Pediatric Crohn's Disease
ClinicalTrials.gov Identifier: NCT00583232 - Recruiting
Crohn's Disease; Protein Metabolism; Energy Metabolism
- CP-461 for the Treatment of Crohn's Disease
ClinicalTrials.gov Identifier: NCT00042055 - Completed
Crohn's Disease
- An Efficacy and Safety Study of Omega-3 Free Fatty Acids (Epanova™) for the Maintenance of Symptomatic Remission in Subjects with Crohn's Disease
ClinicalTrials.gov Identifier: NCT00074542 - Completed
Crohn's Disease
- Evaluation of Urinary Isoprostanes in the Assessment of Children With Inflammatory Bowel Disease
ClinicalTrials.gov Identifier: NCT00215020 - Recruiting
Inflammatory Bowel Disease; Ulcerative Colitis; Crohn's Disease
- Nine-Weeks Treatment With 683699 In Subjects With Moderately-To-Severely Active Crohn's Disease
ClinicalTrials.gov Identifier: NCT00101946 - Terminated
Crohn's Disease
- Corticosteroid Sparing Effect of Certolizumab
ClinicalTrials.gov Identifier: NCT00349752 - Recruiting
Crohn's Disease
- Prevalence of Cytomegalovirus, Epstein Barr Virus and Human Herpes 6 Virus in Inflammatory Bowel Disease
ClinicalTrials.gov Identifier: NCT00222378 - Recruiting
Crohn's Disease; Ulcerative Colitis
- Evaluation of Capsule Endoscopy in Patients With Suspected Crohn’s Disease
ClinicalTrials.gov Identifier: NCT00487396 - Not yet recruiting
Crohn's Disease
- STA-5326 in Crohn's Disease Patients
ClinicalTrials.gov Identifier: NCT00088062 - Completed
Crohn's Disease
[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]
| 
Not Signed In - 
email this page
print this page
bookmark this page
feedback on this page
